Literature DB >> 25291172

Antigenic modulation - a major mechanism of antibody action.

L Chatenoud1, J F Bach.   

Abstract

It is a prudent rule in science that any new indisputable observation is worthy of interest and further investigation, even when it seems a priori anecdotal or outside the scope of current studies. This was the case, in the early 1960s, with antigenic modulation, which was initially considered as an interesting serological curiosity and is now established as a major mechanism of antibody action. In this article Lucienne Chatenoud and Jean-François Bach discuss new roles for antigenic modulation in viral and autoimmune disease pathogenesis and in the escape from tumors and the therapeutic action of monoclonal antibodies.
Copyright © 1984. Published by Elsevier B.V.

Entities:  

Year:  1984        PMID: 25291172     DOI: 10.1016/0167-5699(84)90061-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  4 in total

1.  Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay.

Authors:  W Tilgen; S Matzku; I Kaufmann; M Engstner; J Brüggen; W Dippold; D Petzoldt
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  The clinical use of monoclonal anti-T-cell antibodies.

Authors:  J F Bach; L Chatenoud
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

Review 3.  CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic.

Authors:  Lucienne Chatenoud; Herman Waldmann
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 4.  Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?

Authors:  Shenghua Zong; Carolin Hoffmann; Marina Mané-Damas; Peter Molenaar; Mario Losen; Pilar Martinez-Martinez
Journal:  Front Immunol       Date:  2017-07-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.